Moderna, Inc. - Common Stock (MRNA)

A solid moat favors revenue growth, and that's good news for investors.

The company is coming back into the spotlight thanks to recent developments.

Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month.

Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need to know.

The company may be on track to its next product.

Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in.

These ETFs both hold S&P 500 members but with very different allocations.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f...